Gabelli Merger Plus Trust plc (GMP) Ord USD0.01
Sell:$7.50
Buy:$7.50
0
Change:
No change
No change
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:$7.50
Buy:$7.50
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:$7.50
Buy:$7.50
Change:
No change
No change
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
To seek to generate total return, consisting of capital appreciation and current income. The Company will seek a secondary objective of the protection of capital, uncorrelated to equity and fixed income markets. To meet its investment objective by utilising the Gabelli Private Market Value (PMV) with a CatalystTM, investment methodology, maintaining a diversified portfolio of event merger arbitrage strategies to seek to create an optimal risk/ reward profile for the portfolio. The Company will invest globally although it is expected to have an emphasis on securities traded in the United States, predominantly equity securities issued by companies of any market capitalisation.
| Security | Weight |
|---|---|
| Swedish Match AB | 3.03% |
| Meggitt Plc Swap | 2.88% |
| Shaw Communications Inc B | 2.39% |
| Activision Blizzard Inc | 2.18% |
| Coherent Inc | 2.05% |
| Mandiant Inc | 1.89% |
| Vifor Pharma AG | 1.86% |
| Avast Plc Swap Usd | 1.83% |
| Change Healthcare Inc Ordinary Shares | 1.82% |
| Rogers Corp | 1.77% |
| Sector | Weight |
|---|---|
| Financial Services | 18.80% |
| Technology | 15.33% |
| Healthcare | 8.74% |
| Communication Services | 6.71% |
| Industrials | 6.37% |
| Consumer Cyclical | 5.10% |
| Consumer Defensive | 4.19% |
| Utilities | 3.56% |
| Real Estate | 2.41% |
| Basic Materials | 1.23% |
| Country | Weight |
|---|---|
| United States | 58.50% |
| Sweden | 3.24% |
| United Kingdom | 2.16% |
| Canada | 1.89% |
| Switzerland | 1.86% |
| Israel | 1.61% |
| Italy | 1.56% |
| Germany | 0.98% |
| South Africa | 0.35% |
| Spain | 0.34% |
Fee Structure
Annual management fee of 0.85% of NAV. Contract terminable no less than 3 months notice. The performance fee will be a sum equal to 20% of Adjusted NAV.
Dividend Policy
The Company intends to pay shareholders a quarterly dividend at a minimum fixed annualized dividend rate in relation to the NAV of the Company at the time.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
John BirchChairman, Marc GabelliChairman, John Newlands, Marco Bianconi, Yuji Sugimoto, James Scrymgeour-Wedderburn
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.